MedPath

Brain, Behavior and Endocrine Effects of Transcutaneous Vagus Nerve Stimulation

Not Applicable
Conditions
Healthy
Interventions
Device: Vagus nerve stimulation via tragus
Device: Sham stimulation via earlobe
Registration Number
NCT04890457
Lead Sponsor
University of Electronic Science and Technology of China
Brief Summary

The main aim of the study is to investigate whether the transcutaneous vagus nerve stimulation(tVNS) promotes oxytocin release and the potential biomarkers of tVNS based on eye-tracking data

Detailed Description

A randomized, single-blinded, sham-controlled, within-subject, crossover design will be employed in this study. In a randomized order, a total of 54 healthy subjects will receive transcutaneous vagus nerve stimulation via tragus and sham stimulation vis earlobe in the left ear (interval between these two stimulations will be 1 week). Eye-tracking and behavioral data will be collected before and after 30 minutes of stimulation, saliva samples will be collected before and after 30 minutes of stimulation, and the end of the experiment.

Some personal traits will be assessed using different kinds of questionnaires, such as the Autism Spectrum Quotient(ASQ), Social Responsiveness Scale(SRS), State-Trait Anxiety Inventory (STAI), Beck's Depression Inventory(BDI), and Toronto Alexithymia Scale (TAS-20).

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
54
Inclusion Criteria
  • Healthy subjects without past or current psychiatric or neurological disorders
Exclusion Criteria
  • history of head injury;
  • pregnant, menstruating, taking oral contraceptives;
  • medical or psychiatric illness.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Earlobe then tragus stimulationVagus nerve stimulation via tragus-
Tragus then earlobe stimulationVagus nerve stimulation via tragus-
Earlobe then tragus stimulationSham stimulation via earlobe-
Tragus then earlobe stimulationSham stimulation via earlobe-
Primary Outcome Measures
NameTimeMethod
Oxytocin releaseAfter 30 min tragus stimulation

Investigating the oxytocin release after vagus nerve stimulation via tragus based on saliva samples

Secondary Outcome Measures
NameTimeMethod
The relationship between oxytocin concentration and personal traitsthrough study completion, an average of half an year

Analyzing the correlation between saliva oxytocin concentration and scores on different personal traits

Pupil sizeAfter 30 min tragus stimulation

Investigating whether vagus nerve stimulation via tragus will increase pupil diameter

Trial Locations

Locations (1)

University of Electronic Science and Technology of China

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath